BELLOTTI, VITTORIO
 Distribuzione geografica
Continente #
NA - Nord America 4.364
EU - Europa 3.356
AS - Asia 2.249
AF - Africa 7
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
Totale 9.990
Nazione #
US - Stati Uniti d'America 4.344
CN - Cina 2.197
IE - Irlanda 1.106
UA - Ucraina 596
FI - Finlandia 488
DE - Germania 318
IT - Italia 257
SE - Svezia 248
GB - Regno Unito 180
FR - Francia 86
BE - Belgio 34
IN - India 27
CA - Canada 19
NL - Olanda 8
IR - Iran 7
MU - Mauritius 6
RO - Romania 5
HU - Ungheria 4
PL - Polonia 4
RU - Federazione Russa 4
TR - Turchia 4
AU - Australia 3
CZ - Repubblica Ceca 3
GR - Grecia 3
JP - Giappone 3
LV - Lettonia 3
MY - Malesia 3
NZ - Nuova Zelanda 3
SG - Singapore 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EU - Europa 2
HR - Croazia 2
KR - Corea 2
RS - Serbia 2
TH - Thailandia 2
AT - Austria 1
BO - Bolivia 1
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
ES - Italia 1
HK - Hong Kong 1
KE - Kenya 1
MX - Messico 1
PT - Portogallo 1
Totale 9.990
Città #
Dublin 1.105
Chandler 1.033
Jacksonville 752
Nanjing 659
Nanchang 276
Ashburn 266
Beijing 235
Princeton 222
Wilmington 200
Shenyang 199
Hebei 185
Lawrence 184
Ann Arbor 176
Changsha 162
Medford 154
Helsinki 143
Jiaxing 135
Boardman 102
Tianjin 97
Hangzhou 91
Woodbridge 75
Milan 69
Shanghai 47
New York 46
Pavia 41
Falls Church 40
Verona 40
Brussels 34
Norwalk 30
Piscataway 27
Fairfield 22
Los Angeles 17
Jinan 16
Auburn Hills 15
Seattle 14
Toronto 14
Kunming 11
Ningbo 11
Washington 11
Houston 9
Guangzhou 7
Zhengzhou 7
Chandigarh 6
Fuzhou 6
Padova 6
Taizhou 6
Dearborn 5
Hefei 5
Lanzhou 5
London 5
Orange 5
Redmond 5
Tappahannock 5
Budapest 4
Des Moines 4
Formia 4
Hanover 4
Redwood City 4
Rome 4
Saint Albans 4
San Giuliano Milanese 4
Berlin 3
Boston 3
Catania 3
Changchun 3
Leawood 3
Pune 3
Rockville 3
San Francisco 3
Zanjan 3
Andover 2
Arlington 2
Ban Kho 2
Belgrade 2
Birmingham 2
Borås 2
Brescia 2
Brunswick 2
Bucharest 2
Cardito 2
Falkenstein 2
Feldthurns 2
Genova 2
Groningen 2
Hyderabad 2
Kamien 2
Marsciano 2
Melbourne 2
Mountain View 2
Narbonne 2
Nieuwegein 2
Novokuznetsk 2
Palazzolo 2
Polska 2
Rho 2
Romainville 2
Takamatsu 2
Victoria 2
West Jordan 2
Zagreb 2
Totale 7.157
Nome #
L'ipotesi della cascata amiloide nella malattia di Alzheimer: studi su strategie di neuroprotezione. 140
Susceptibility to AA amyloidosis in rheumatic diseases: A critical overview. 98
Hepatitis C virus-associated cryoglobulinaemicglomerulonephritis with delayed appearance of monoclonal cryoglobulinaemia. 95
C. elegans expressing human beta2-microglobulin: a novel model for studying the relationship between the molecular assembly and the toxic phenotype. 90
A specific nanobody prevents amyloidogenesis of D76N β2-microglobulin in vitro and modifies its tissue distribution in vivo 85
WALDENSTROM'S HYPERGLOBULINEMIC PURPURA IN HLA IDENTICAL SISTERS. 84
D-strand perturbation and amyloid propensity in beta-2 microglobulin. 84
The H50Q mutation induces a tenfold decrease in the solubility of α-synuclein. 84
Search of ligands for the amyloidogenic protein beta(2)-microglobulin by capillary electrophoresis and other techniques 82
Biological activity and pathological implications of misfolded proteins. 80
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils:inhibition of amyloidogenesis. 80
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. 77
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits. 77
Beta 2- microglobulin can be refolded into a native state from ex vivo amyloid fibrils 76
AMYLOIDOSIS AL 75
Identification and characterization of a new ligand-binding site in FnbB, a fibronectin-binding adhesin from Streptococcus dysgalactiae 75
Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis. 75
CHRONIC LYMPHOCYTIC LEUKAEMIA OR IDIOPATHIC COLD HAEMAGGLUTININ DISEASE? A DILEMMA RAISED BY AN ERRONEOUS ELECTRONIC CELL COUNT 73
USE OF A MONOCLONAL ANTIBODY AGAINST HUMAN HEART FERRITIN FOR EVALUATING ACIDIC FERRITIN CONCENTRATION IN HUMAN SERUM 73
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy 73
Liver biopsy discloses a new apolipoprotein AI hereditary amyloidosis in several unrelated Italian families 71
Sulfonated molecules that bind a partially structured species of beta2-microglobulin also influence refolding and fibrillogenesis. 71
Affinity capillary electrophoresis is a powerful tool to identify transthyretin binding drugs for potential therapeutic use in amyloidosis 71
Amino acid sequence of k Sci, the Bence Jones protein isolated from a patient with light chain deposition disease. 70
Heparin strongly enhances the formation of beta 2-microglobulin amyloid fibrils in the presence of type I collagen 70
AN INTERLEUKIN 2 BINDING FACTOR IN HUMAN SERUM 68
DE loop mutations affect beta2-microglobulin stability and amyloid aggregation 68
“Separation and quantification of two beta2-microglobulin isoforms”. 67
Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure. 67
Structural characterization of kappa II Inc, a new amyloid immunoglobulin 66
Use of an anti-idiotypic monoclonal antibody in studying amyloidogenic light chains in cells, urine and fibrils: pathophysiology and clinical implications. 66
AL amyloidosis. Characterization of amyloidogenic cells by anti-idiotypic monoclonal antibodies 66
Capillary electrophoresis studies on the aggregation process of beta-amyloid 1-42 and 1-40 peptides 65
Metodo per la separazione e la quantificazione di due conformazioni di beta-2-microglobulina in equilibrio dinamico 65
Collagen plays an active role in the aggregation of beta 2-microglobulin under physio-pathological conditions of dialysis-related amyloidosis. 64
beta 2-microglobulin H31Y variant 3D-structure highlights the protein natural propensity towards intermolecular aggregation 64
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. 64
Anatomic and Clinical Clues to in vivo mechanisms of amyloidogenesis. in , (2005) vol. 1, pp.29-48. 63
Class I Major Histocompatibility Complex, the Trojan horse for secretion of amyloidogenic β2-microglobulin. 63
Capillary electrophoresis investigation of a partially unfolded conformation of Beta 2-microglobulin. 63
RELEVANCE OF CLASS, MOLECULAR WEIGHT AND ISOELECTRIC POINT IN PREDICTING HUMAN LIGHT CHAIN AMYLOIDOGENICITY. 62
IMMUNOENZYMATIC DETECTION OF PROTEINS TRANSFERRED ON NITROCELLULOSE AFTER FIXATION AND STAINING IN POLYACRYLAMIDE GEL 62
Cinetiche di refolding e studi di affinità mediante elettroforesi capillare: effetto di ligandi di interesse farmaceutico sulla conformazione della Beta 2-microglobulina 62
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 61
Use of anti-(beta2 microglobulin) mAb to study formation of amyloid fibrils 61
Characterization of the two unique human anti-flavin monoclonal immunoglobulins. 61
PLASMA FERRITIN DETERMINATION AS A DIAGNOSTIC TOOL 60
Topological investigation of amyloid fibrils obtained from beta2-microglobulin 60
Proteomics of beta2-microglobulin amyloid fibrils. 60
Detection of two partially structured species in the folding process of the amyloidogenic protein beta 2-microglobulin 60
{beta}2-microglobulin is potentially neurotoxic, but the blood brain barrier is likely to protect the brain from its toxicity. 60
Atomic structure of a nanobody trapped domain swapped dimer of an amyloidogenic β2-microglobulin variant 60
Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman's disease. 60
Conformational transition and cellular toxicity by amyloidogenic proteins 59
Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases. 59
Citrate-stabilized gold nanoparticles hinder fibrillogenesis of a pathological variant of β2-microglobulin 59
SELECTIVE BONE MARROW INVOLVMENT OF LYMPHOPLASMACYTIC CELLS SECRETING MONOCLONAL IGA RHEUMATOID FACTOR IN A PATIENT WITH SJORGREN'S SYNDROME AND SERUM HYPERVISCOSITY. 58
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. 58
Nanobodies against beta2-microglobulin. 58
Studies on neuroprotective strategy based on the amyloid cascade hypothesis 58
Current concepts on the pathogenisis of systemic amyloidosis 57
The controlling roles of Trp60 and Trp95 in beta2-microglobulin function, folding and amyloid aggregation properties. 57
A recurrent D-strand association interface is observed in β-2 microglobulin oligomers. 57
Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis 57
Solution structure of beta(2)-microglobulin and insights into fibrillogenesis 56
Defect of platelet aggregation and adhesion induced by autoantibody against glycoprotein IIIa. 56
Cerebrospinal fluid ferritin in human disease. 56
Fibrillogenesis of human beta2-microglobulin in three-dimensional silicon microstructures 56
The potential of capillary electrophoresis in the study of amyloidoses 55
Towards understanding the molecular pathogenesis of monoclonal immunoglobulin light-chain deposition 55
Lysozyme: A paradigmatic molecule for the investigation of protein structure, function and misfolding 55
Enhanced toxicity of silver nanoparticles in transgenic Caenorhabditis elegans expressing amyloidogenic proteins 55
Effect of tetracyclines on the dynamics of formation and destructuration of {beta}2-microglobulin amyloid fibrils. 55
A partially structured species of beta 2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis 55
Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients 54
Co-fibrillogenesis of Wild-type and D76N β2-Microglobulin: THE CRUCIAL ROLE OF FIBRILLAR SEEDS 54
Preliminary crystallographic characterization of the human beta2 microglobulin His31Tyr mutant in a tetrameric assembly. 53
Folding intermediates and transient oligomers: difficult protein targets to find new drugs for amyloidoses 53
Lysozyme 53
Enhanced molecular chaperone activity of the small heat-shock protein αB-crystallin following covalent immobilization onto a solid-phase support. 53
Biochimica Applicata 53
An Asp to Asn mutation is a toxic trigger in beta-2 microglobulin: structure and biophysics 53
Clinical evaluation of erythrocyte zinc-protoporphyrin as a parameter of iron status in man. 53
Conformational dynamics of the beta2-microglobulin C terminal in the cell-membrane-anchored major histocompatibility complex type I 53
Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosis 53
IMMUNOCHEMICAL CHARACTERISTICS OF A PARTICULAR CRYOGLOBULIN. A NEW CRYOGLOBULIN SUBGROUP? 52
Development of a method to screen potential ligands of amyloidogenic proteins 52
Protein Aggregation 52
Effects of the Known Pathogenic Mutations on the Aggregation Pathway of the Amyloidogenic Peptide of Apolipoprotein A-I. 52
Dynamic of beta(2)-microglobulin fibril formation and reabsorption: the role of proteolysis. 51
Characterization of apo(a) polymorphism by a modified immunoblotting techniques in an Italian population sample 51
Pharmaceutical strategies against amyloidosis: old and new drugs in targeting a "protein misfolding disease". REVIEW ARTICLE 51
Neurodegenerative diseases caused by protein aggregation: a phenomenon at the borderline between molecular evolution and ageing. 51
CHARACTERIZATION OF ANTI-STREPTOLYSIN O ACTIVITY OF A HUMAN MONOCLONAL IgG LAMDA. 51
Plasminogen activation triggers transthyretin amyloidogenesis in vitro 51
Molecular dynamics simulation suggests possible interaction patterns at early steps of beta2-microglobulin aggregation 50
The two tryptophans of β2-microglobulin have distinct roles in function and folding and might represent two independent responses to evolutionary pressure. 50
Gene expression of pyrogenic cytokines in Hodgkin's disease lymph nodes. 50
CLINICAL EVALUATION OF ERYTROCYTE ZINC-PROTOPORPHYRIN AS A PARAMETER OF IRON STATUS IN MAN. 50
Bifunctional crosslinking ligands for transthyretin 50
Totale 6.337
Categoria #
all - tutte 35.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.034


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201931 0 0 0 0 0 0 0 0 0 0 6 25
2019/20202.579 769 1.047 6 112 12 113 23 125 3 212 146 11
2020/20211.154 156 101 31 111 11 161 8 183 49 167 144 32
2021/2022905 15 7 11 13 28 56 18 64 58 36 132 467
2022/20233.045 365 239 26 219 315 280 0 160 1.307 20 64 50
2023/2024900 136 202 40 57 104 222 12 48 8 41 30 0
Totale 10.224